North America Pulmonary Function Testing Systems Market

The North America pulmonary function testing systems market was valued at US$ 108.42 million in 2022 and is expected to reach US$ 160.73 million by 2028; it is estimated to register a CAGR of 6.8% from 2022 to 2028.

Rising Incidence of Lung-Related Disorders Fuels North America Pulmonary Function Testing Systems Market

The PFT systems provide accurate results, particularly lung volume, capacity, rates of flow, and gas exchange. PFT systems utilization assists in assessing treatment for asthma, emphysema, and other chronic lung problems. Through the assessment of lung volumes, capacities, rates of flow, and gas exchange, PFTs can provide information that can be evaluated by physicians to help diagnose certain lung disorders effectively and decide the right treatment for patients. Further, PFTs are noninvasive procedures and are usually recommended by physicians for patients with no hospital stay. Spirometry is a type of commercial pulmonary function testing system. Spirometry testing is useful for determining if the patient is suffering from lung disease, type of lung disease, progression of the lung disease, and impairment of lung disease. Spirometry measures airflow and can evaluate a broad range of lung diseases among patients. Thus, the rising incidence of lung-related disorders is fueling the use of pulmonary function testing systems in North America.

North America Pulmonary Function Testing Systems Market Overview

The North America pulmonary function testing systems market is segmented into the US, Canada, and Mexico. The US held the largest share of the North America pulmonary function testing systems market in 2022. The North America pulmonary function testing systems market growth is attributed to the high implementation of portable systems and a rise in the usage of respiratory devices among the physician groups (clinics) in the region.

North America Pulmonary Function Testing Systems Market Revenue and Forecast to 2028 (US$ Million)

North America Pulmonary Function Testing Systems Strategic Insights

Strategic insights for the North America Pulmonary Function Testing Systems provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Pulmonary Function Testing Systems Report Scope

North America Pulmonary Function Testing Systems Regional Insights

The geographic scope of the North America Pulmonary Function Testing Systems refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Pulmonary Function Testing Systems Market Segmentation

The North America pulmonary function testing systems market is segmented on the basis of type, test type, component, application, end user, and country.

Based on type, the North America pulmonary function testing systems market is bifurcated into cart-based PFT systems and stationery PFT systems. The cart-based PFT systems segment held a larger share of the North America pulmonary function testing systems market in 2022.

Based on test type, the North America pulmonary function testing systems market is segmented into spirometry, lung volume, gas exchange testing, maximum voluntary ventilation, oxygen titration test, and others. The spirometry segment held the largest share of the North America pulmonary function testing systems market in 2022.

Based on component, the North America pulmonary function testing systems market is segmented into hardware, software, and services. The hardware segment held the largest share of the North America pulmonary function testing systems market in 2022.

Based on application, the North America pulmonary function testing systems market is segmented into chronic obstructive pulmonary disorder, asthma, chronic shortness of breath, restrictive lung disease, and others. The chronic obstructive pulmonary disorder segment held the largest share of the North America pulmonary function testing systems market in 2022.

Based on end-user, the North America pulmonary function testing systems market is segmented into hospitals, specialty clinics, and diagnostic laboratories. The hospitals segment held the largest share of the North America pulmonary function testing systems market in 2022.

Based on country, the North America pulmonary function testing systems market is segmented into the US, Canada, and Mexico. The US dominated the share of the North America pulmonary function testing systems market in 2022.   

COSMED Srl, KoKo PFT Ltd, MGC Diagnostics Corp, Morgan Scientific Inc, ndd Medical Technologies Inc, PulmOne Advanced Medical Devices Ltd, Schiller AG, and Vyaire Medical Inc are the leading companies operating in the North America pulmonary function testing systems market.